IDNA Stock Overview
IDNA Genomics Public Ltd engages in the field of genomics and biotechnology and specializes in personalized health care.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
IDNA Genomics Public Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €27.40 |
| 52 Week High | €27.80 |
| 52 Week Low | €26.00 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 1.48% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 14.17% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| IDNA | CY Healthcare | CY Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | -0.6% |
| 1Y | n/a | -7.5% | 33.6% |
Return vs Industry: Insufficient data to determine how IDNA performed against the CY Healthcare industry.
Return vs Market: Insufficient data to determine how IDNA performed against the CY Market.
Price Volatility
| IDNA volatility | |
|---|---|
| IDNA Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 3.0% |
| 10% most volatile stocks in CY Market | 10.0% |
| 10% least volatile stocks in CY Market | 2.2% |
Stable Share Price: IDNA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IDNA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | n/a | www.idnagenomicsplc.com |
IDNA Genomics Public Ltd engages in the field of genomics and biotechnology and specializes in personalized health care. The company develops and provides genetic tests in the field of genomics. It also develops and markets pharmaceutical products.
IDNA Genomics Public Ltd Fundamentals Summary
| IDNA fundamental statistics | |
|---|---|
| Market cap | €75.63m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs IDNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDNA income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did IDNA perform over the long term?
See historical performance and comparison